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Project Summary 
Overview 
My name is Salahuddin Mohammed, a 2nd year PhD graduate student from Dr. Jason 
Paris’ Lab. My research dissertation focuses on investigating the neuroendocrine 
underpinnings of HIV- and opioid-mediated anxiety-/depression-like behavior and 
cognitive impairment via experiments utilizing humans and animal models. Through this 
work I strive to delineate the underlying mechanism for the neuroHIV symptomology and 
develop novel therapeutic agents which can ameliorate HIV-1 mediated Tat-neurotoxicity. 
Approximately 50% of the HIV infected patients suffer from HIV associated neurocognitive 
disorders (HAND) which can be exacerbated by drug use/abuse. Some neuroHIV 
symptoms include anxiety, major depressive disorder, neurocognitive impairment, and 
additional psychiatric comorbidities that impair the quality of life (QOL) like and increased 
abuse risk for opioids, alcohol, psychostimulants, etc. One protein, the HIV-1 regulatory 
protein, trans-activator of transcription (Tat), may contribute to neuropathology by 
promoting neuroinflammation and neurotoxicity which may be exacerbated by opioids like 
oxycodone. The underlying mechanisms for the neuroHIV symptomology are unknown. 
Moreover, the HIV+ population is commonly prescribed opioids like oxycodone (Merlin et 
al., 2016) which may further raise concerns about HIV-1 Tat and oxycodone interactions. 
Evidence shows that 20-80% of HIV+ patients may have a dysregulated hypothalamic-
pituitary-adrenal (HPA) stress axis (usually characterized by high basal stress hormones 
with a lack of appropriate hormonal response to additional stressors). Preliminary findings 
from our lab use a mouse model of HIV-1 Tat exposure. These mice demonstrate higher 
circulating stress hormone (i.e. corticosterone) when exposed to the HIV-1 Tat protein 
and appear to recapitulate the human phenotype. These mice may be used to assess the 
underlying mechanisms within the brain that cause HPA dysregulation associated with 
HIV and, thus, may be used as a model with which to screen treatments for this disorder.  
Intellectual Merit 
The present project will delineate the neurocircuitry involved in HIV-protein-mediated 
dysregulation of the stress axis. This work will further provide sites to be targeted to 
restore HPA stress axis homeostasis and reduce the overall burden of present and future 
neurological sequela in HIV+ patients. 
External Opportunity 
The findings will be presented at the Society for Neuroscience (SfN) conference 
scheduled for this year November 13– 21, 2021 at Chicago, IL, U.S.A. The conference is 
expected to be attended by approximately 30,000 scientists from over 80 countries. My 
attendance at this conference would greatly help me to garner structured feedback and 
insights from experts in this domain. Attending this meeting would also provide 
opportunities to learn relevant cellular and molecular advancements in the fields of 
neuroscience. Moreover, I would be enthusiastic to meet leaders in fields of sex 
differences and opioids/HIV research such as Drs. Pamela Knapp, Margaret McCarthy, 
Georgia Hodes, Oliver Hobert, Wendy Macklin, and others. I believe attendance at this 
conference will have a formative impact on my career. Additionally, this grant may also 
help me to apply for extramural Sigma Xi society funding which provides fellowship of 
$1000 to graduate students with application deadline of October 1 every year. This grant 
will advance my scientific fluency, professional development, and capacity for building my 
CV.  
